Literature DB >> 22177960

Immunization schedule of the Spanish Association of Pediatrics: 2012 recommendations.

D Moreno-Pérez1, F J Alvarez García, J Aristegui Fernández, F Barrio Corrales, M J Cilleruelo Ortega, J M Corretger Rauet, J González-Hachero, T Hernández-Sampelayo Matos, M Merino Moína, L Ortigosa del Castillo, J Ruiz-Contreras.   

Abstract

The Advisory Committee on Vaccines of the Spanish Association of Pediatrics (CAV-AEP) updates the immunization schedule every year, taking into account epidemiological data as well as evidence on the effectiveness and efficiency of vaccines. The present schedule includes grades of recommendation. We have graded as routine vaccinations those that the CAV-AEP believes all children should receive; as recommended those that fit the profile for universal childhood immunization and would ideally be given to all children, but that can be prioritized according to the resources available for their public funding; and as risk group vaccinations those that specifically target individuals in situations of risk. Immunization schedules tend to be dynamic and adaptable to ongoing epidemiological changes. Nevertheless, the achievement of a unified immunization schedule in all regions of Spain is a top priority for the CAV-AEP. Based on the latest epidemiological trends, the main changes introduced to the schedule are the administration of the first dose of the MMR and the varicella vaccines at age 12 months (12-15 months) and the second dose at age 2-3 years, as well as the administration of the Tdap vaccine at age 4-6 years, always followed by another dose at 11-14 years of age. The CAV-AEP believes that the coverage of vaccination against human papillomavirus in girls aged 11-14 years must increase. It reasserts its recommendation to include vaccination against pneumococcal disease in the routine immunization schedule. Universal vaccination against varicella in the second year of life is an effective strategy and therefore a desirable objective. Vaccination against rotavirus is recommended in all infants due to the morbidity and elevated healthcare burden of the virus. The Committee stresses the need to vaccinate population groups considered at risk against influenza and hepatitis A. Finally, it emphasizes the need to bring incomplete vaccinations up to date following the catch-up immunization schedule.
Copyright © 2011 Asociación Española de Pediatría. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22177960     DOI: 10.1016/j.anpedi.2011.10.008

Source DB:  PubMed          Journal:  An Pediatr (Barc)        ISSN: 1695-4033            Impact factor:   1.500


  3 in total

1.  2009 H1N1: risk factors for hospitalization in a matched case-control study.

Authors:  Cristian Launes; Juan-José García-García; Aina Martínez-Planas; Fernando Moraga; Itziar Astigarraga; Javier Arístegui; Javier Korta; Concepción Salado; José M Quintana; Núria Soldevila; Angela Domínguez
Journal:  Eur J Pediatr       Date:  2012-03-21       Impact factor: 3.183

Review 2.  Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.

Authors:  Paul L McCormack
Journal:  Drugs       Date:  2012-09-10       Impact factor: 9.546

3.  Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2-59 Months of Age, Spain.

Authors:  Sergi Hernández; Fernando Moraga-Llop; Alvaro Díaz; Mariona F de Sevilla; Pilar Ciruela; Carmen Muñoz-Almagro; Gemma Codina; Magda Campins; Juan José García-García; Cristina Esteva; Conchita Izquierdo; Sebastià González-Peris; Johanna Martínez-Osorio; Sonia Uriona; Luis Salleras; Ángela Domínguez
Journal:  Emerg Infect Dis       Date:  2020-06       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.